𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apolipoprotein B-associated cholesterol is a determinant of treatment outcome in patients with chronic hepatitis C virus infection receiving anti-viral agents interferon-alpha and ribavirin

✍ Scribed by D. A. SHERIDAN; D. A. PRICE; M. L. SCHMID; G. L. TOMS; P. DONALDSON; D. NEELY; M. F. BASSENDINE

Book ID
108605637
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
121 KB
Volume
29
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A mutation in the interferon sensitivity
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1b
✍ Mutsumi Murayama; Yoshiaki Katano; Isao Nakano; Masatoshi Ishigami; Kazuhiko Hay 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

## Abstract The interferon sensitivity‐determining region (ISDR) is useful as a predictive marker of the response to interferon (IFN) therapy for chronic hepatitis patients with a Japan‐specific subtype (J‐type) of hepatitis C virus (HCV) genotype 1b. This marker is not useful for predicting respon

Early viral kinetics and treatment outco
Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral load
✍ Akihito Tsubota; Yasuji Arase; Takashi Someya; Yoshiyuki Suzuki; Fumitaka Suzuki 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 138 KB 👁 2 views

## Abstract An investigation was carried out to determine whether early viral monitoring could predict efficiently the virological response to combination therapy of two different regimens in treatment‐naïve chronic hepatitis C patients infected with genotype 1b with high baseline viral load. Patie

Pretreatment virus load and multiple ami
Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity–determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection
✍ K Chayama; A Tsubota; M Kobayashi; K Okamoto; M Hashimoto; Y Miyano; H Koike; M 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB 👁 3 views

biochemical and histological improvement. 3,4 Several factors Hepatitis C virus (HCV) genotype 1b and high precan predict a poor response to interferon therapy, e.g., high treatment virus load are predictive factors of poor repretreatment virus load, genotype 1b, advanced histological sponse to inte